Market research
NRTH.V 48North Cannabis Corp
V CAD Healthcare
Latest close
As of 05 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.35
- Dividend yield
- 0.0%
- Beta
- 1.29
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA34978F1036
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.35
- Dividend yield
- 0.0%
- Beta
- 1.29
About
About 48North Cannabis Corp
48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada. As of September 1, 2021, 48North Cannabis Corp. operates as a subsidiary of HEXO Corp.
Research context
48North Cannabis Corp appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the NRTH.V discussion.
5 years, 6 months ago
48North Cannabis Corp is currently in a long term downtrend where the price is trading 14.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
48North Cannabis Corp's total revenue rose by 271.7% to $6M since the same quarter in the previous year.
Its net income has dropped by 16.0% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $-4M since the same quarter in the previous year.
Based on the above factors, 48North Cannabis Corp gets an overall score of 3/5.